The increase in price target by a reputable analyst like Goldman Sachs suggests a positive reassessment of Ducommun's stock value, potentially leading to increased investor interest and a short-term positive impact on the stock price. The Neutral rating indicates that while the stock might not outperform the market, the increased price target suggests an upward revision in the expected stock value.